Advanced Search

Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2012 June;147(3) > Giornale Italiano di Dermatologia e Venereologia 2012 June;147(3):269-76

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEGIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases

Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,677

Frequency: Bi-Monthly

ISSN 0392-0488

Online ISSN 1827-1820

Giornale Italiano di Dermatologia e Venereologia 2012 June;147(3):269-76

AUTOIMMUNE BULLOUS DISEASES 

Rituximab for autoimmune blistering diseases: recent studies, new insights

Lunardon L., Payne A. S.

Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA

Rituximab, an anti-CD20 monoclonal antibody, has been successfully used off-label for treatment of autoimmune blistering diseases. We discuss rituximab mechanisms of action, host factors that may affect response to rituximab, and the efficacy and safety of rituximab in autoimmune blistering diseases, incorporating recent data on the use of rituximab in other autoimmune disease patients.

language: English


FULL TEXT  REPRINTS

top of page